Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK).
Saito M, Yamashita K, Arimura Y, Kaneto H, Okuda H, Nojima M, Hagiwara T, Suzuki K, Adachi T, Goto A, Nakachi K, Yawata A, Yoshimoto M, Tanuma T, Adachi Y, Yamaoka S, Mizukoshi T, Kawayama M, Hamamoto Y, Shinomura Y.
Saito M, et al. Among authors: yamashita k.
Acta Oncol. 2016;55(3):309-17. doi: 10.3109/0284186X.2015.1107189. Epub 2016 Jan 12.
Acta Oncol. 2016.
PMID: 26757197